|
E80020-1
|
Epigentek Group Inc
|
SARS-CoV-2 Spike S1 (13-665) Protein, Fc Fusion, Avi-tag
|
SARS-CoV-2
|
|
|
|
E80020-2
|
Epigentek Group Inc
|
SARS-CoV-2 Spike S1 (13-665) Protein, Fc Fusion, Avi-tag
|
SARS-CoV-2
|
|
|
|
E80021-1
|
Epigentek Group Inc
|
SARS-CoV-2 Spike S1 (16-685) Protein, Avi-His-tag
|
SARS-CoV-2
|
|
|
|
E80021-2
|
Epigentek Group Inc
|
SARS-CoV-2 Spike S1 (16-685) Protein, Avi-His-tag
|
SARS-CoV-2
|
|
|
|
E80022-1
|
Epigentek Group Inc
|
SARS-CoV-2 Spike S1 (16-685) Protein, Fc Fusion, Avi-tag
|
SARS-CoV-2
|
|
|
|
E80022-2
|
Epigentek Group Inc
|
SARS-CoV-2 Spike S1 (16-685) Protein, Fc Fusion, Avi-tag
|
SARS-CoV-2
|
|
|
|
E80023-1
|
Epigentek Group Inc
|
SARS-CoV-2 Spike S1 RBD (V367F) Protein, Avi-His-tag
|
SARS-CoV-2
|
|
|
|
E80023-2
|
Epigentek Group Inc
|
SARS-CoV-2 Spike S1 RBD (V367F) Protein, Avi-His-tag
|
SARS-CoV-2
|
|
|
|
E80024-1
|
Epigentek Group Inc
|
SARS-CoV-2 Spike S1 RBD Protein, Avi-His-tag
|
SARS-CoV-2
|
|
|
|
E80024-2
|
Epigentek Group Inc
|
SARS-CoV-2 Spike S1 RBD Protein, Avi-His-tag
|
SARS-CoV-2
|
|
|
|
E80025-1
|
Epigentek Group Inc
|
SARS-CoV-2 Spike S1 RBD Protein, Human Fc-Fusion, Avi-Tag
|
SARS-CoV-2
|
|
|
|
E80025-2
|
Epigentek Group Inc
|
SARS-CoV-2 Spike S1 RBD Protein, Human Fc-Fusion, Avi-Tag
|
SARS-CoV-2
|
|
|
|
E80026-1
|
Epigentek Group Inc
|
SARS-CoV-2 Spike S1 RBD Protein, Mouse Fc-fusion
|
SARS-CoV-2
|
|
|
|
E80026-2
|
Epigentek Group Inc
|
SARS-CoV-2 Spike S1 RBD Protein, Mouse Fc-fusion
|
SARS-CoV-2
|
|
|
|
E80027-1
|
Epigentek Group Inc
|
SARS-CoV-2 Nucleocapsid Protein, Avi-His-tag
|
SARS-CoV-2
|
|
|
|
E80027-2
|
Epigentek Group Inc
|
SARS-CoV-2 Nucleocapsid Protein, Avi-His-tag
|
SARS-CoV-2
|
|
|
|
E80028-1
|
Epigentek Group Inc
|
SARS-CoV-2 Nucleocapsid Protein, Avi-His-tag
|
SARS-CoV-2
|
|
|
|
E80028-2
|
Epigentek Group Inc
|
SARS-CoV-2 Nucleocapsid Protein, Avi-His-tag
|
SARS-CoV-2
|
|
|
|
E80029-1
|
Epigentek Group Inc
|
Recombinant SARS-COV-2 S1+S2 ECD(S-ECD) Protein with His tag (Pre-Fusion)
|
SARS-CoV-2
|
|
|
|
A73671-100
|
Epigentek Group Inc
|
SARS-CoV-2 N Recombinant Antibody
|
SARS-CoV-2
|
ELISA, GICA; Recommended dilution: ELISA 1:10000-1:50000, GICA 1:500-1:20000
|
|
|
A73672-100
|
Epigentek Group Inc
|
SARS-CoV-2 S Recombinant Antibody
|
SARS-CoV-2
|
ELISA, GICA, Neutralization; Recommended dilution: ELISA 1:10000-1:50000, GICA 1:500-1:40000, Neutralization 1:100-1:10000
|
|
|
A73673-050
|
Epigentek Group Inc
|
SARS-CoV-2 S Recombinant Antibody, HRP Conjugated
|
SARS-CoV-2
|
ELISA; Recommended dilution: ELISA 1:10000-1:50000
|
|
|
A73673-100
|
Epigentek Group Inc
|
SARS-CoV-2 S Recombinant Antibody, HRP Conjugated
|
SARS-CoV-2
|
ELISA; Recommended dilution: ELISA 1:10000-1:50000
|
|
|
A73674-050
|
Epigentek Group Inc
|
SARS-CoV-2 S Recombinant Antibody, FITC Conjugated
|
SARS-CoV-2
|
ELISA; Recommended dilution: ELISA 1:10000-1:50000
|
|
|
A73674-100
|
Epigentek Group Inc
|
SARS-CoV-2 S Recombinant Antibody, FITC Conjugated
|
SARS-CoV-2
|
ELISA; Recommended dilution: ELISA 1:10000-1:50000
|
|
